Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience

Conclusion In this series, pazopanib showed interesting activity in DSRCT patients who progressed after prior chemotherapy without major toxicity.
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research